At the time there were strict guidelines limiting the use of recombinant DNA technology a form of genetic engineering in warm-blooded animals
Moss Professor of Diabetes at the University of Virginia School of Medicine and former chief of UVA Healths Division of Endocrinology and Metabolism
doi: 10.1186/s12964-020-00663-1 48 LongYTaoHKarachiAGrippinAJJinLChangYEet al
However, CJC-1295 is not FDA approved for general use, and dosage should not be self-directed
doi: 10.3390/ijms232314631, Summary Keywords GLP-1/GIP dual agonist, metabolic regulation, obesity, obstructive sleep apnea, tirzepatide Citation Fang Q, Zhu Y, Rao M and Liu P (2026) GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives
They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)